COVID-19 vaccines: The status and perspectives in delivery points of view

JY Chung, MN Thone, YJ Kwon - Advanced drug delivery reviews, 2021 - Elsevier
Due to the high prevalence and long incubation periods often without symptoms, the severe
acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected millions of individuals …

Role of inflammatory cytokines in COVID-19 patients: A review on molecular mechanisms, immune functions, immunopathology and immunomodulatory drugs to …

AA Rabaan, SH Al-Ahmed, J Muhammad, A Khan… - Vaccines, 2021 - mdpi.com
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), is a severe pandemic of the current century. The vicious …

Amyloidogenesis of SARS-CoV-2 spike protein

S Nystrom, P Hammarstrom - Journal of the American Chemical …, 2022 - ACS Publications
SARS-CoV-2 infection is associated with a surprising number of morbidities. Uncanny
similarities with amyloid-disease associated blood coagulation and fibrinolytic disturbances …

JAK-STAT pathway inhibition and their implications in COVID-19 therapy

S Satarker, AA Tom, RA Shaji, A Alosious… - Postgraduate …, 2021 - Taylor & Francis
As the incidence of COVID-19 increases with time, more and more efforts are made to pave
a way out for the therapeutic strategies to deal with the disease progression. Inflammation …

A global picture: therapeutic perspectives for COVID-19

VP Chavda, C Kapadia, S Soni, R Prajapati… - …, 2022 - Taylor & Francis
The COVID-19 pandemic is a lethal virus outbreak by severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2), which has severely affected human lives and the global …

A dual-role of SARS-CoV-2 nucleocapsid protein in regulating innate immune response

Y Zhao, L Sui, P Wu, W Wang, Z Wang, Y Yu… - … and Targeted Therapy, 2021 - nature.com
The recently emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
which is the causative agent of ongoing global pandemic of COVID-19, may trigger …

The triumvirate of NF-κB, inflammation and cytokine storm in COVID-19

A Attiq, LJ Yao, S Afzal, MA Khan - International immunopharmacology, 2021 - Elsevier
Abstract The coronavirus disease (COVID-19) has once again reminded us of the
significance of host immune response and consequential havocs of the immune …

Antiviral strategies targeting host factors and mechanisms obliging+ ssRNA viral pathogens

S Mahajan, S Choudhary, P Kumar, S Tomar - Bioorganic & Medicinal …, 2021 - Elsevier
The ongoing COVID-19 pandemic, periodic recurrence of viral infections, and the
emergence of challenging variants has created an urgent need of alternative therapeutic …

COVID-19 Impairs Immune Response to Candida albicans

D Moser, K Biere, B Han, M Hoerl, G Schelling… - Frontiers in …, 2021 - frontiersin.org
Infection with SARS-CoV-2 can lead to Coronavirus disease-2019 (COVID-19) and result in
severe acute respiratory distress syndrome (ARDS). Recent reports indicate an increased …

SARS-CoV-2 causes severe epithelial inflammation and barrier dysfunction

S Deinhardt-Emmer, S Böttcher, C Häring… - Journal of …, 2021 - Am Soc Microbiol
Infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can be
asymptomatic, but they can also be accompanied by a variety of symptoms that result in mild …